Narendra Veerapaneni, MD
Hospitalist · Milwaukee, WINPI 1477784379
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $767 of the $904 with a category attached, or 84.8%. 11 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 27.2% of the total. Reporting peaked in 2022 at $408 and has fallen 72.1% since, to $114 in 2025. Among hospitalist clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $45.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$246
- Astellas Pharma US Inc$137
- GSK$128
- Johnson & Johnson$119
- Amgen$114
- AstraZeneca$46
- plus $114 from 5 others
What the payments were for
- Food & beverage$76785%
- Education$13715%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 3 | $246 |
| Astellas Pharma US Inc | 2 | $137 |
| GSK | 2 | $128 |
| Johnson & Johnson | 2 | $119 |
| Amgen | 1 | $114 |
| AstraZeneca(2 entities) | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $41 |
| Merck | 2 | $32 |
| Boston Scientific | 1 | $16 |
| AbbVie | 1 | $12 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$234
- Tavneos$114
- TRELEGY ELLIPTA$110
- XARELTO$105
How this compares
$904 in reported general payments places this provider in the 90th percentile of 679 hospitalist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Midodrine Hcl | 13 | $304 |
| Prednisone | 13 | $25 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Milwaukee
- Muhammad Bilal AbidMilwaukee$89K
- Aradhana PathakMilwaukee$45K
- Ankur SegonMilwaukee$35K
- Siddhartha SinghMilwaukee$26K
- Carlos MendezMilwaukee$18K
- Harsimran SekhonMilwaukee$11K
- Umair BajwaMilwaukee$8K
- Wamiq BandayMilwaukee$6K
- Fadi AljabiMilwaukee$5K
- Aymen KhogaliMilwaukee$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.